SLC1A5 and cancer: Then, this feature revealed a hallmark of human cancers and, consequently, ASCT2 has been elected as a pharmacological target for specifically blocking cancer cells growth and development (Ganapathy et al., 2009; Bhutia and Ganapathy, 2016; Bröer, 2018).